Member Info for EyeGuy

push coming. just like yesterday.

Align agree. The 3p sp is based on a fraction of that.
These potential target prices may look high compared to the current market price, but that is largely, in our view, due to the shares being tremendously oversold and that fears over a drawn out litigation/arbitration process have held the stock back. As per the RNS yesterday, it seems to us that Oilex are now in a strong position and that there will very likely to be political pressure within India to come to a resolution, finally.

We believe by any conventional yardstick that the shares are very inexpensive. We also point out that the true potential at the Cambay Field PSC is a lot higher – the 145 Bcf planned to be produced until 2029 represents just a fraction of the resources here. We in fact see our model and our valuation as actually representing a base case that does not account for further extension or an even larger expansion. An additional government approval would be required to extend the PSC beyond 2029.

We initiated coverage on Oilex in November 2017 with a target price of 1.60p and a Conviction Buy stance. Given the events of recent weeks and the points highlighted here where the base value is near 3 times the stock price and the “blue sky” multiples of this, we believe that the current price now provides an even more attractive risk/reward entry than when coverage was initiated. Accordingly we remain resolute buyers at this level.

Reading.
Align are saying no deal and it’s 3p but they think that’s a base price based on a fraction of the resource.
It’s all here
http://www.alignresearch.co.uk/oilex/oilex-court-ruling-update/

Paul- assets worth much more for NPV if you look at align report.
Their estimation is based on a fraction of the field

3p base on no pay according to align
That’s 7 x this

We initiated coverage on Oilex in November 2017 with a target price of 1.60p and a Conviction Buy stance. Given the events of recent weeks and the points highlighted here where the base value is near 3 times the stock price and the “blue sky” multiples of this, we believe that the current price now provides an even more attractive risk/reward entry than when coverage was initiated. Accordingly we remain resolute buyers at this level.

North- Hudson and China Sonangol are private numb nuts.
The loans are secured. Yes. Likely On BZM’s assets - which you say don’t exist.
No idea what you are doing here fella

Wow. 3p base is possible on scenario 2. That is only a fraction of the field.
Think we will be seeing 1p over next few sessions

Lmao. Actually you are quite funny northcoat. You make a statement which actually contradicts the rest of your post

Northcoat. Answer the question then.
Why would Hudson lose $20 million of loans owed to them rather than dilute their shareholding to under 50%??
We are all ears mr expert.

Moved to 41 v 40 now. Should move higher now imo

They ain’t going to pay imo. They have no means to pay.
3p someone stated on no pay rns. That would be lovely

Yep news soon

http://www.alignresearch.co.uk/wp-content/uploads/2017/11/Oilex_Initiation_Align_Research_16th_November_2017.pdf

Last years target - 4 bagger from here

Babbler- don’t forget about that one imo. I’ve been adding

Wolf? Are you ?

Morning babbler. Got it yesterday at 0.3p here. You do know who the non exec director is here?
Paul Heywood.

From rns
The principal amount currently outstanding is £1,177,240.00 and the scheduled maturity date of the notes concerned is 31 December 2018.

That’s only £200k worth.
There is £1.2 million to redeem by year end

Helu- im surprised there has been no additional loan note conversion notices.
As it stands with £800k to £1 mill left, shares will be converted at 0.675p which will mean upto another 150 million shares hitting in the next 7 weeks unless news drives it forward.
Real shame as I detest loan note conversions because essentially the shares are presold and converted. But that means the loan note holders are essentially short which means the price gets lower and their % margin increases.
Not dermamping before anyone says so. Just need news to drive them out